Targeted αGalCer/CD1d Therapy Engages Invariant Natural Killer T Cells to Facilitate Cardiac Healing in Chronic Doxorubicin-Induced Cardiomyopathy
Sarojini Singh, Roopa Hebbandi Nanjundappa, Harish Babu Kolla…·Channakeshava Sokke Umeshappa
This study investigates the role of iNKT cells in cardiac healing using GalCer/CD1d therapy in a Doxorubicin-induced cardiomyopathy model, finding increased IFN-γ and IL-10 without worsening cardiac damage.